{"id":"W4386565810","doi":"10.1016/s2213-2600(23)00297-7","title":"Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective","year":2023,"lang":"en","type":"review","venue":"The Lancet Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; NIHR Imperial Biomedical Research Centre; National Center for Advancing Translational Sciences; Medical Research Council; Bundesministerium für Gesundheit; Canadian Institutes of Health Research; National Institutes of Health; National Health and Medical Research Council; Engineering and Physical Sciences Research Council; Institut National de la Santé et de la Recherche Médicale; Deutsche Forschungsgemeinschaft; Bundesministerium für Bildung und Forschung; Insmed; CSL Behring; National Institute for Health and Care Research; Cystic Fibrosis Trust; Chiesi Farmaceutici; LifeArc; Vertex Pharmaceuticals; Chiesi USA; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Gilead Sciences; Genentech; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Clinical trial; Medicine; Population; Cystic fibrosis transmembrane conductance regulator; Disease; Intensive care medicine; Bioinformatics; Pathology; Internal medicine; Biology; Environmental health","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03197969,0.0009720625,0.01134646,0.0001969038,0.0002585913,0.00003840306,0.001446272,0.0004581992,0.0002257705],"category_scores_gemma":[0.07186388,0.0003792161,0.001296134,0.003040659,0.001890718,0.00008220755,0.000390899,0.002466226,0.0001020903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006630215,"about_ca_system_score_gemma":0.004831344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003542133,"about_ca_topic_score_gemma":0.0003630549,"domain_scores_codex":[0.9833389,0.007387805,0.004458198,0.001154485,0.002285214,0.001375431],"domain_scores_gemma":[0.965394,0.02708837,0.003183951,0.00290306,0.0006810923,0.0007495593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05431164,0.0001251611,0.00002790297,0.007836668,0.001845194,0.0001577987,0.0001592614,0.00002644007,0.000001644441,0.0007840169,0.2734819,0.6612424],"study_design_scores_gemma":[0.03517719,0.006316278,0.00006431261,0.05167904,0.006712832,0.0001158682,0.0004525772,0.0000422482,3.067266e-7,0.0007194982,0.8983911,0.0003287636],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001056524,0.9822776,0.001483603,0.005165636,0.001313783,0.007881599,0.0001505382,0.0002075057,0.001509207],"genre_scores_gemma":[0.00001147353,0.949528,0.001421059,0.0009236529,0.0466078,0.0004468346,0.00006310226,0.000163557,0.0008345669],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6609136,"threshold_uncertainty_score":0.9998659,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3386867880027096,"score_gpt":0.546564949404477,"score_spread":0.2078781614017674,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}